Log In
BCIQ
Print this Print this
 

PSD503

  Manage Alerts
Collapse Summary General Information
Company Plethora Solutions Holdings plc
DescriptionTopical gel formulation of phenylephrine
Molecular Target Adrenergic receptor alpha (ADRA)
Mechanism of ActionAdrenoceptor alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat stress urinary incontinence (SUI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$789.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/01/2016

$789.0M

0

0

07/27/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today